DarioHealth Corp.

Equities

DRIO

US23725P2092

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2024 BST			5-day change	1st Jan Change
1.35 ^USD	-6.90%		+12.50%	-21.51%

07-16	DarioHealth Secures New Contract to Provide Cardiometabolic Solutions	MT
07-16	DarioHealth Corp. Expands GLP-1 Solution Client Base with New Employer Contract	CI

DarioHealth Introduces iPhone 7, iPhone 8, and iPhone X Compatible Smart Glucose Meter to the Australian Market

January 17, 2018 at 01:30 pm

DarioHealth Corp. announced it has launched the Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System in the Australian market. The Lightning®-enabled device ensures that Apple consumers "Down Under" will be able to connect the Dario smart glucose meter to the latest iOS handsets, including the brand-new iPhone X.

Latest news about DarioHealth Corp.

DarioHealth Secures New Contract to Provide Cardiometabolic Solutions	07-16	MT
DarioHealth Corp. Expands GLP-1 Solution Client Base with New Employer Contract	07-16	CI
DarioHealth Corp.(NasdaqCM:DRIO) dropped from Russell Microcap Growth Index	06-30	CI
DarioHealth Corp.(NasdaqCM:DRIO) dropped from Russell 3000E Growth Index	06-30	CI
DarioHealth Appoints Steven Nelson as Chief Commercial Officer	06-05	MT
DarioHealth Corp. Announces Management Changes	06-05	CI
Transcript : DarioHealth Corp., Q1 2024 Earnings Call, May 15, 2024	05-15
Earnings Flash (DRIO) DARIOHEALTH Reports Q1 Revenue $5.8M, vs. Street Est of $6.8M	05-15	MT
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	04-25	CI
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	04-18	CI
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	04-10	CI
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	04-02	CI
Transcript : DarioHealth Corp., 2023 Earnings Call, Mar 28, 2024	03-28
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
North American Morning Briefing : Stocks Set for -2-	03-28	DJ
North American Morning Briefing : Investors -2-	03-21	DJ
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	03-12	CI
Transcript : DarioHealth Corp., Twill, Inc. - M&A Call	02-21
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	02-21	CI
DarioHealth Corp. announced that it has received $22.422 million in funding	02-20	CI
DarioHealth Corp. acquired Twill, Inc. for $34.4 million.	02-20	CI
DarioHealth Corp. announced that it expects to receive $22.422 million in funding	02-14	CI
DarioHealth to Provide Diabetes, Weight-Control Services for Food Services Union Members	01-11	MT
Regional Union Selects DarioHealth Corp.'s Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support	01-11	CI

Chart DarioHealth Corp.

Duration

Period

More charts

Company Profile

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Sector

Medical Equipment, Supplies & Distribution

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for DarioHealth Corp.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.35 USD

Average target price

5.667 USD

Spread / Average Target

+319.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
DARIOHEALTH CORP.	-21.51%	43.39M
ABBOTT LABORATORIES	-6.68%	179B
MEDTRONIC PLC	-5.20%	98.84B
BECTON, DICKINSON AND COMPANY	-5.38%	65.34B
HOYA CORPORATION	+17.76%	45.41B
DEXCOM, INC.	-6.47%	44.94B
CENCORA, INC.	+9.74%	43.76B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.01%	29.01B
TERUMO CORPORATION	+21.16%	25.65B
WEST PHARMACEUTICAL SERVICES, INC.	-6.53%	23.32B

Other Medical Equipment, Supplies & Distribution